George Pappas
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2020First federal award
$3.5MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $3.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 22, 2025 | NIH | SBIR Phase II Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $864K | SCHEDULE 1 THERAPEUTICS INC |
| Sep 19, 2024 | NIH | SBIR Phase II Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $2.0M | SCHEDULE 1 THERAPEUTICS INC |
| Sep 30, 2020 | NIH | STTR Phase I Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $308K | SCHEDULE 1 THERAPEUTICS INC with UNIVERSITY OF IOWA |
| Sep 15, 2020 | NIH | STTR Phase I Optimization of Cannabinoids for Development as FDA-Approved Migraine Therapeutics | $308K | SCHEDULE 1 THERAPEUTICS INC |
Peer ranks
Federal funding#492
Awards as PI#566
Patents#273
Companies
- SCHEDULE 1 THERAPEUTICS INCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.